On August 28, 2023 Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, reported that management will be presenting virtually at the H.C. Wainwright 25th Annual Global Investment Conference (Press release, Panbela Therapeutics, AUG 28, 2023, https://panbela.com/press-release/panbela-to-present-at-h-c-wainwright-25th-annual-global-investment-conference/?utm_source=rss&utm_medium=rss&utm_campaign=panbela-to-present-at-h-c-wainwright-25th-annual-global-investment-conference [SID1234634715]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Interested parties may access the presentation beginning on September 11 at 7:00 A.M. (ET) via View Source Management will also be available for virtual one-on-one meetings. For additional information about the conference, visit View Source